- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 26, 2024
Companies with a Value score of at least 3, ordered by Value score
457 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AMPH | US$41.11 | 2.7% | 14.9% | US$2.0b | US$62.60 | PE14.6x | E19.7% | n/a | ||
EXAS | US$58.85 | -3.5% | -8.1% | US$10.8b | US$89.37 | PS4.3x | E61.9% | n/a | ||
SPPI | US$1.03 | 5.3% | 17.0% | US$209.9m | US$1.26 | PS8.2x | E67.3% | n/a | ||
AKYA | US$3.80 | 0% | -45.4% | US$187.6m | US$9.00 | PS1.9x | E55.3% | n/a | ||
SUPN | US$30.07 | 2.3% | -18.4% | US$1.6b | US$40.33 | PE1250.7x | E58.3% | n/a | ||
INSM | US$24.80 | 2.0% | 27.2% | US$3.7b | US$44.13 | PS12.1x | E39.2% | n/a | ||
OCUP | US$1.61 | -2.7% | -68.6% | US$39.9m | US$19.50 | PS2.1x | E9.5% | n/a | ||
INCY | US$51.68 | -1.3% | -30.5% | US$11.6b | US$75.20 | PE19.4x | E18.8% | n/a | ||
BIO | US$275.94 | -1.4% | -38.8% | US$7.9b | US$428.90 | PS2.9x | E81.3% | n/a | ||
AMRN | US$0.87 | 1.8% | -35.2% | US$359.3m | US$1.08 | PS1.2x | E51.1% | n/a | ||
SCYX | US$1.54 | 6.9% | -51.1% | US$58.2m | US$6.88 | PE0.9x | E0.04% | n/a | ||
JUSH.F | US$0.67 | 4.9% | 45.6% | US$131.1m | US$1.08 | PE-2x | S6.1% | n/a | ||
FOLD | US$10.28 | -3.1% | -10.9% | US$3.0b | US$18.78 | PS7.6x | E55.6% | n/a | ||
INDV | UK£17.58 | -5.1% | -6.2% | UK£1.9b | UK£30.96 | PE476.7x | E34.7% | 0% | ||
GILD | US$65.42 | -2.0% | -20.4% | US$81.6b | US$84.25 | PE168.2x | E33.6% | 4.7% | ||
PRGO | US$31.94 | 3.7% | -14.1% | US$4.3b | US$39.72 | PB0.9x | E46.9% | 3.5% | ||
AMRX | US$5.87 | 8.3% | 204.1% | US$1.8b | US$7.31 | PB91.6x | E104.9% | 0% | ||
MDXG | US$6.27 | -0.3% | 63.7% | US$925.3m | US$12.44 | PE16.6x | E15.0% | n/a | ||
SNCE | US$5.75 | 0.3% | 30.9% | US$34.7m | US$13.83 | PB0.7x | E66.7% | n/a | ||
TCNN.F | CA$10.57 | -1.6% | 95.4% | CA$2.7b | CA$16.45 | PS1.8x | E116.2% | n/a | ||
CDXC | US$3.44 | -6.8% | 160.6% | US$259.6m | US$6.08 | PS3.1x | E93.2% | n/a | ||
EVO | €5.02 | -29.0% | -45.7% | €1.6b | €13.43 | PS2.1x | E55.2% | n/a | ||
ADPT | US$2.60 | 8.3% | -63.6% | US$377.2m | US$6.67 | PS2.2x | E22.8% | n/a | ||
BAYZ.F | €29.08 | 3.1% | -56.3% | €26.9b | €39.17 | PB0.8x | E46.3% | 0.4% |